Short answer
NovoCure Ltd (NVCR) filed an 8-K current report with the SEC on April 24, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). CEO Leonard’s base salary set at CHF 750,000, with target annual cash bonus equal to 90% of salary.
NovoCure Ltd 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CEO Leonard’s base salary set at CHF 750,000, with target annual cash bonus equal to 90% of salary
- Relocation, tax equalization, Swiss wealth-tax indemnification, and six months of COBRA reimbursement increase executive-related costs
- Pre-change-in-control qualifying termination triggers 12 months’ base salary continuation
- Post-change-in-control qualifying termination triggers 200% of base salary plus 200% of target bonus
- Equity awards fully vest upon post-change-in-control qualifying termination, increasing transaction-related compensation exposure
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NovoCure Ltd 8-K filings
Get the next NVCR 8-K as it lands
Follow NVCR for push alerts, or ask the research agent what this filing means.